These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10350394)

  • 21. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    Foldes M; Munro R; Sorrell TC; Shanker S; Toohey M
    J Antimicrob Chemother; 1983 Jan; 11(1):21-6. PubMed ID: 6826485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro kinetics of the activity of fusidic acid and fluoroquinolones combinations against staphylococci according to methicillin-resistance phenotype. Implications for the treatment of osteoarticular infections].
    Reynaud AE; Espaze EP; Coste-Burel M; Richet H
    Pathol Biol (Paris); 1992 May; 40(5):466-70. PubMed ID: 1495828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination of resistance to the antibiotic staphylomycin].
    Roser H
    Med Klin; 1966 Jun; 61(23):919-21. PubMed ID: 4863570
    [No Abstract]   [Full Text] [Related]  

  • 24. Penetration of sodium fusidate (Fucidin) in the synovial cavity.
    Deodhar SD; Russell F; Dick WC; Nuki G; Buchanan WW
    Scand J Rheumatol; 1972; 1(1):33-9. PubMed ID: 4659178
    [No Abstract]   [Full Text] [Related]  

  • 25. In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
    Norazah A; Lim VK; Rohani MY; Kamel AG
    Med J Malaysia; 2005 Oct; 60(4):411-5. PubMed ID: 16570701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro activity of ciprofloxacin combined with either fusidic acid or rifampicin against Staphylococcus aureus.
    Røder BL; Gutschik E
    J Antimicrob Chemother; 1989 Mar; 23(3):347-52. PubMed ID: 2732119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concentrations of some antibiotics in synovial fluid after oral administration, with special reference to antistaphylococcal activity.
    Sattar MA; Barrett SP; Cawley MI
    Ann Rheum Dis; 1983 Feb; 42(1):67-74. PubMed ID: 6830326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.
    Rijnders MI; Wolffs PF; Hopstaken RM; den Heyer M; Bruggeman CA; Stobberingh EE
    J Antimicrob Chemother; 2012 May; 67(5):1176-80. PubMed ID: 22290345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections.
    Liu Y; Geng W; Yang Y; Wang C; Zheng Y; Shang Y; Wu D; Li X; Wang L; Yu S; Yao K; Shen X
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):212-8. PubMed ID: 22066960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis.
    Alsterholm M; Flytström I; Bergbrant IM; Faergemann J
    Acta Derm Venereol; 2010; 90(1):52-7. PubMed ID: 20107726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloxacillin-resistant staphylococci in a children's hospital.
    Skirrow MB; Rogers KB
    J Clin Pathol; 1971 Feb; 24(1):48-52. PubMed ID: 5206516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
    Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM;
    Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
    Fernández Guerrero ML; de Górgolas M
    J Antimicrob Chemother; 2006 Nov; 58(5):1066-9. PubMed ID: 16931540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survey, characterization and susceptibility to fusidic acid of Staphylococcus aureus in the Carmarthen area.
    El-Zimaity D; Kearns AM; Dawson SJ; Price S; Harrison GA
    J Antimicrob Chemother; 2004 Aug; 54(2):441-6. PubMed ID: 15269197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco).
    Elazhari M; Abu-Quatouseh LF; Elhabchi D; Zerouali K; Dersi N; Saile R; Timinouni M; Becker K
    Int J Med Microbiol; 2012 Mar; 302(2):96-100. PubMed ID: 22197537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum and synovial vancomycin concentrations following prophylactic administration in knee arthroplasty.
    Eshkenazi AU; Garti A; Tamir L; Hendel D
    Am J Knee Surg; 2001; 14(4):221-3. PubMed ID: 11703034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between fusidic acid and penicillins.
    O'Grady F; Greenwood D
    J Med Microbiol; 1973 Nov; 6(4):441-50. PubMed ID: 4491548
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of fusidic acid in therapy of experimental Staphylococcus aureus meningitis.
    Østergaard C; Yieng-Kow RV; Knudsen JD; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 2003 May; 51(5):1301-5. PubMed ID: 12697637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of salicylate and related compounds on fusidic acid MICs in Staphylococcus aureus.
    Price CT; O'Brien FG; Shelton BP; Warmington JR; Grubb WB; Gustafson JE
    J Antimicrob Chemother; 1999 Jul; 44(1):57-64. PubMed ID: 10459810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of Cefuroxime in Synovial Fluid.
    Schwameis R; Syré S; Marhofer D; Appelt A; Burau D; Sarahrudi K; Kloft C; Zeitlinger M
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.